Company ApicHope Pharmaceutical Co., Ltd

Equities

300723

CNE1000035J7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
22.24 CNY -1.59% Intraday chart for ApicHope Pharmaceutical Co., Ltd +4.46% -25.44%

Business Summary

ApicHope Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of drugs. The Company has two types of products which are children's drugs and chronic disease drugs. The children's drugs are used for the treatment of colds, digestive anorexia, viral infections, children's eczema and other diseases, including clindamycin palmitate dispersible tablets and clindamycin palmitate granules. The chronic disease drugs include hepatocyte growth-promoting hormone for injection, aceglutamine for injection and adenosine cyclophosphate for injection, which are used for the treatment of severe viral hepatitis and cardiovascular and cerebrovascular diseases. The Company is also engaged in selling drugs for agents.

Number of employees: 1,386

Sales per Business

CNY in Million2021Weight2022Weight Delta
Pharmaceutical Manufacturing Children's Medicine
57.6 %
1,130 51.4 % 1,313 57.6 % +16.20%
Pharmaceutical Manufacturing Chronic Disease Drugs
34.6 %
823 37.4 % 789 34.6 % -4.13%
Pharmaceutical Manufacturing Other Medicines
5.1 %
62 2.8 % 117 5.1 % +89.72%
Medicine and Other Services
2.7 %
185 8.4 % 61 2.7 % -66.94%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
2,199 100.0 % 2,280 100.0 % +3.68%

Managers

Managers TitleAgeSince
Chief Executive Officer 50 02-02-03
Director of Finance/CFO 58 07-12-31
Director/Board Member 57 03-12-31
Corporate Secretary 39 22-09-05

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 50 02-02-03
Director/Board Member 56 02-12-31
Director/Board Member 57 03-12-31
Chairman 48 06-12-31
Director/Board Member 49 18-11-22
Director/Board Member 39 18-11-22
Director/Board Member 66 18-11-22
Director/Board Member 38 18-11-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 454,143,281 140,722,039 ( 30.99 %) 0 30.99 %

Shareholders

NameEquities%Valuation
41,688,000 18.60 % 147 M ¥
14,006,970 6.251 % 49 M ¥
Tibet Rongchuang Investment Co. Ltd.
4.338 %
9,720,000 4.338 % 34 M ¥
Shenzhen Sunshine Jinrui Investment Co. Ltd.
3.031 %
6,791,431 3.031 % 24 M ¥
Li Family
2.711 %
6,075,000 2.711 % 21 M ¥
Essence Fund Co., Ltd.
2.367 %
5,304,196 2.367 % 19 M ¥
5,097,312 2.275 % 18 M ¥
Da Cheng Fund Management Co., Ltd.
1.841 %
4,125,510 1.841 % 14 M ¥
Huashang Fund Management Co., Ltd.
1.698 %
3,804,014 1.698 % 13 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
1.671 %
3,744,267 1.671 % 13 M ¥
NameEquities%Valuation
166,752,000 72.48 % 586 M ¥
20,389,248 8.862 % 72 M ¥
Li Family
7.922 %
18,225,000 7.922 % 64 M ¥
10,228,848 4.446 % 36 M ¥
7,771,816 3.378 % 27 M ¥

Company contact information

ApicHope Pharmaceutical Co., Ltd.

15-19/F, Yunrun Buldg 27 Huanyu 1st Rd, GZ Intl Bio Island

510623, Guangzhou

+

http://www.gdyph.com
address ApicHope Pharmaceutical Co., Ltd(300723)

Sales per Business

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
22.24 CNY
Average target price
32.98 CNY
Spread / Average Target
+48.28%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300723 Stock
  4. Company ApicHope Pharmaceutical Co., Ltd